Resistance to Immunotherapy in Breast Cancer Check for updates
BP Damane, LT Maebele, M Makgoka… - … Breast Cancer Therapy … - books.google.com
Breast cancer is the most common and second most deadly disease in women worldwide,
with breast cancer screening resulting in a steady decline in mortality rate. However, early …
with breast cancer screening resulting in a steady decline in mortality rate. However, early …
Resistance to Immunotherapy in Breast Cancer
BP Damane, LT Maebele, M Makgoka… - … Breast Cancer Therapy …, 2024 - Springer
Breast cancer is the most common and second most deadly disease in women worldwide,
with breast cancer screening resulting in a steady decline in mortality rate. However, early …
with breast cancer screening resulting in a steady decline in mortality rate. However, early …
Understanding resistance to immune checkpoint inhibitors in advanced breast cancer
P Tarantino, R Barroso-Sousa… - Expert Review of …, 2022 - Taylor & Francis
Introduction The addition of immune checkpoint inhibitors (ICIs) to frontline chemotherapy
has improved survival for patients with advanced triple-negative breast cancer (TNBC) …
has improved survival for patients with advanced triple-negative breast cancer (TNBC) …
Immunotherapy for breast cancer: New strategies to enhance the patient selection and overcome therapeutic resistance
R Scafetta, A Carnevale, G Castellano… - Principles of …, 2025 - Elsevier
Breast cancer (BC) is a significant global health challenge, representing the main cause of
morbidity and mortality for all women. Prognosis of breast cancer is variable, according to …
morbidity and mortality for all women. Prognosis of breast cancer is variable, according to …
[PDF][PDF] Breast Cancer Immunotherapy: From Biology to Current Clinical Applications
JHS Leal, H McArthur - Eur. Med. J, 2020 - emjreviews.com
Therapeutic strategies for the treatment of breast cancer have historically been determined
by the presence or absence of hormone receptors and HER2 amplification and/or protein …
by the presence or absence of hormone receptors and HER2 amplification and/or protein …
Novel classes of immunotherapy for breast cancer
Immune-checkpoint inhibitors have profoundly changed the treatment landscape for many
tumor types. Despite marked improvements in disease control for highly immunogenic …
tumor types. Despite marked improvements in disease control for highly immunogenic …
Immune checkpoint inhibitors and novel immunotherapy approaches for breast cancer
M Cejuela, A Vethencourt, S Pernas - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review To critically review the existing evidence on immune checkpoint
inhibitors (ICIs) in early-stage and metastatic breast cancer and discuss emerging strategies …
inhibitors (ICIs) in early-stage and metastatic breast cancer and discuss emerging strategies …
Current treatment and future trends of immunotherapy in breast cancer
Immunotherapy continues to redefine the solid tumor treatment landscape, with inhibitors of
the PD-L1/PD-1 immune checkpoint having the most widespread impact. As the most …
the PD-L1/PD-1 immune checkpoint having the most widespread impact. As the most …
[HTML][HTML] What is the role of immunotherapy in breast cancer
The immune system plays a complex role in the recognition/prevention, early eradication as
well as progression of cancer. Recently, we have witnessed great momentum in the field of …
well as progression of cancer. Recently, we have witnessed great momentum in the field of …
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology
C Criscitiello, E Guerini-Rocco, G Viale… - Anti-Cancer Agents …, 2022 - ingentaconnect.com
Immune Checkpoint Inhibitors (ICIs) have remarkably modified the way solid tumors are
managed, including breast cancer. Unfortunately, only a relatively small number of breast …
managed, including breast cancer. Unfortunately, only a relatively small number of breast …